donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 03347 Tigermed > Company Profile
03347 Tigermed
77.950
-0.800-1.02%
Symbol
03347
Company Name
Tigermed
ISIN
CNE1000040M1
Listing Date
08/07/2020
Establishment Date
12/15/2004
Registration
China
Chairman
Xiaoping Ye
Secretary
Yanqun He
Audit Institution
Hong Kong Lixin Dehao Accounting firm Co., Ltd.
Company Category
Mainland registration of Mainland Individuals control
Registered Office
Room 2001-2010, 20 / F, Building 8, No. 19 Jugong Road, Xixing Street, Binjiang District, Hangzhou City, Zhejiang Province
Head Office and Principal Place of Business
40 / F, Dah Sing Financial Centre, 248 Queen's Road East, Wanchai, Hong Kong
Fiscal Year Ends
12-31
Employees
8326
Market
Hong Kong motherboard
Phone
(0571)89986795
Fax
(0571)88211196
Email
IR@tigermedgrp.com
Business
Hangzhou Tiger Pharmaceutical Technology Co., Ltd. is a Chinese holding company engaged in providing clinical trial services for new drug research and development. The company operates two branches. The Clinical trial Technical Services Division provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies to help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical trial related Services and Laboratory Services Division is engaged in providing analytical services, such as data management and statistical analysis; logistical and executive support services, such as clinical trial site management; administrative assistance, such as patient recruitment; and consulting services. The division, through its subsidiaries, also provides laboratory services for preclinical and clinical development phases. The company operates in both domestic and overseas markets.
Profile
Tiger Pharmaceutical (stock code: 300347) is a contract research organization (CRO) focused on providing professional services for the whole process of clinical trials for new drug research and development, providing comprehensive and comprehensive clinical research services and solutions for global pharmaceutical and medical device innovation enterprises, reducing R & D risk, shortening R & D cycle, saving R & D funds, promoting product marketization process, so that patients can use newer and better medicine and medical products as soon as possible. Tiger Pharmaceutical is headquartered in Hangzhou, with 46 subsidiaries and 123 service outlets in major cities of Chinese mainland, Hong Kong and Taiwan. In addition, overseas service outlets have been set up in 10 countries and regions, including South Korea, Japan, Malaysia, the United States and Europe, with an international professional team of more than 5200 people.
Company Overview
Hangzhou Tiger Pharmaceutical Technology Co., Ltd. is a Chinese holding company engaged in providing clinical trial services for new drug research and development. The company operates two branches. The Clinical trial Technical Services Division provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies to help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical trial related Services and Laboratory Services Division is engaged in providing analytical services, such as data management and statistical analysis; logistical and executive support services, such as clinical trial site management; administrative assistance, such as patient recruitment; and consulting services. The division, through its subsidiaries, also provides laboratory services for preclinical and clinical development phases. The company operates in both domestic and overseas markets.
CEO: Xiaoping Ye
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...